118 related articles for article (PubMed ID: 9522188)
1. [Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)].
Trcka J; Kämpgen E; Becker JC; Schwaaf A; Bröcker EB
Hautarzt; 1998 Jan; 49(1):17-22. PubMed ID: 9522188
[TBL] [Abstract][Full Text] [Related]
2. Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.
Terheyden P; Kortüm AK; Schulze HJ; Durani B; Remling R; Mauch C; Junghans V; Schadendorf D; Beiteke U; Jünger M; Becker JC; Bröcker EB
J Cancer Res Clin Oncol; 2007 Jul; 133(7):437-44. PubMed ID: 17334785
[TBL] [Abstract][Full Text] [Related]
3. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
[TBL] [Abstract][Full Text] [Related]
4. Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma.
Strobbe LJ; Hart AA; Rümke P; Israels SP; Nieweg OE; Kroon BB
Melanoma Res; 1997 Dec; 7(6):507-12. PubMed ID: 9464624
[TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model.
Wack C; Becker JC; Bröcker EB; Lutz WK; Fischer WH
Melanoma Res; 2001 Jun; 11(3):247-53. PubMed ID: 11468513
[TBL] [Abstract][Full Text] [Related]
6. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
Illig L; Paul E
Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
[TBL] [Abstract][Full Text] [Related]
7. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
[TBL] [Abstract][Full Text] [Related]
8. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
Kirchner HH; Atzpodien J; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
[TBL] [Abstract][Full Text] [Related]
9. Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).
Illig L; Paul E; Bödeker RH
Anticancer Res; 1984; 4(4-5):293-8. PubMed ID: 6486734
[TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.
Trefzer U; Sterry W
Dermatology; 2005; 211(4):370-1. PubMed ID: 16286751
[No Abstract] [Full Text] [Related]
11. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
[No Abstract] [Full Text] [Related]
12. Successful treatment of in-transit melanoma metastases using topical 2-4 dinitrochlorobenzene.
von Nida J; Quirk C
Australas J Dermatol; 2003 Nov; 44(4):277-80. PubMed ID: 14616496
[TBL] [Abstract][Full Text] [Related]
13. An attempt at topical DNCB immunomodulation in advanced malignant melanoma.
Budzanowska E; Pawlicki M
Tumori; 1988 Oct; 74(5):519-22. PubMed ID: 3217986
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of Paclitaxel and Dacarbazine with filgrastim administration in advanced malignant melanoma.
Feun LG; Savaraj N; Hurley J; Marini A
Cancer Invest; 2002; 20(3):357-61. PubMed ID: 12025231
[TBL] [Abstract][Full Text] [Related]
15. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
Duchková H; Richter J; Kubíková M
Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
[No Abstract] [Full Text] [Related]
16. [Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma].
Gershanovich ML; Akimov MA
Vopr Onkol; 2004; 50(2):179-83. PubMed ID: 15176220
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant DNCB immunotherapy in malignant melanoma].
Weidner F; Djawari D
Z Hautkr; 1979 May; 54(10):436-43. PubMed ID: 473840
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
Budzanowska E; Pawlicki M
Przegl Dermatol; 1988; 75(1):29-34. PubMed ID: 3290999
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
Tan EH; Ang PT
Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
Weber JS; Zarour H; Redman B; Trefzer U; O'Day S; van den Eertwegh AJ; Marshall E; Wagner S
Cancer; 2009 Sep; 115(17):3944-54. PubMed ID: 19536884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
